Excellent communications - as we have come to expect from RECCE. Go to company website if you can't wait!!
Recce Clinical Pipeline Update
Sydney Australia, 7 June 2021: Recce Pharmaceuticals Ltd (ASX:RCE) (FSE:R9Q) (Company), the
Company developing New Classes of Synthetic Anti-infectives, is pleased to provide an updated
timeline on its clinical programs with several significant clinical data read-outs in 2021 and beyond.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
44.5¢ |
Change
0.080(21.9%) |
Mkt cap ! $128.6M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 44.5¢ | 37.5¢ | $191.2K | 477.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12222 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 10976 | 2 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |